Literature DB >> 12930944

Poly(ADP-ribose) polymerase (PARP-1) has a controlling role in homologous recombination.

Niklas Schultz1, Elena Lopez, Nasrollah Saleh-Gohari, Thomas Helleday.   

Abstract

Cells with non-functional poly(ADP-ribose) polymerase (PARP-1) show increased levels of sister chromatid exchange, suggesting a hyper recombination phenotype in these cells. To further investigate the involvement of PARP-1 in homologous recombination (HR) we investigated how PARP-1 affects nuclear HR sites (Rad51 foci) and HR repair of an endonuclease-induced DNA double-strand break (DSB). Several proteins involved in HR localise to Rad51 foci and HR-deficient cells fail to form Rad51 foci in response to DNA damage. Here, we show that PARP-1 mainly does not localise to Rad51 foci and that Rad51 foci form in PARP-1-/- cells, also in response to hydroxyurea. Furthermore, we show that homology directed repair following induction of a site-specific DSB is normal in PARP-1-inhibited cells. In contrast, inhibition or loss of PARP-1 increases spontaneous Rad51 foci formation, confirming a hyper recombination phenotype in these cells. Our data suggest that PARP-1 controls DNA damage recognised by HR and that it is not involved in executing HR as such.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12930944      PMCID: PMC212803          DOI: 10.1093/nar/gkg703

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  39 in total

1.  Negative regulation of alkylation-induced sister-chromatid exchange by poly(ADP-ribose) polymerase-1 activity.

Authors:  R Meyer; M Müller; S Beneke; J H Küpper; A Bürkle
Journal:  Int J Cancer       Date:  2000-11-01       Impact factor: 7.396

2.  Sister chromatid gene conversion is a prominent double-strand break repair pathway in mammalian cells.

Authors:  R D Johnson; M Jasin
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

3.  Potential role for the BLM helicase in recombinational repair via a conserved interaction with RAD51.

Authors:  L Wu; S L Davies; N C Levitt; I D Hickson
Journal:  J Biol Chem       Date:  2001-02-08       Impact factor: 5.157

4.  Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage.

Authors:  R Scully; J Chen; R L Ochs; K Keegan; M Hoekstra; J Feunteun; D M Livingston
Journal:  Cell       Date:  1997-08-08       Impact factor: 41.582

Review 5.  Functions of poly(ADP-ribose) polymerase (PARP) in DNA repair, genomic integrity and cell death.

Authors:  Z Herceg; Z Q Wang
Journal:  Mutat Res       Date:  2001-06-02       Impact factor: 2.433

6.  DNA double-strand breaks associated with replication forks are predominantly repaired by homologous recombination involving an exchange mechanism in mammalian cells.

Authors:  C Arnaudeau; C Lundin; T Helleday
Journal:  J Mol Biol       Date:  2001-04-13       Impact factor: 5.469

7.  Chromosomal aberrations in PARP(-/-) mice: genome stabilization in immortalized cells by reintroduction of poly(ADP-ribose) polymerase cDNA.

Authors:  C M Simbulan-Rosenthal; B R Haddad; D S Rosenthal; Z Weaver; A Coleman; R Luo; H M Young; Z Q Wang; T Ried; M E Smulson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

8.  Werner helicase relocates into nuclear foci in response to DNA damaging agents and co-localizes with RPA and Rad51.

Authors:  S Sakamoto; K Nishikawa; S J Heo; M Goto; Y Furuichi; A Shimamoto
Journal:  Genes Cells       Date:  2001-05       Impact factor: 1.891

9.  Chromosome instability and defective recombinational repair in knockout mutants of the five Rad51 paralogs.

Authors:  M Takata; M S Sasaki; S Tachiiri; T Fukushima; E Sonoda; D Schild; L H Thompson; S Takeda
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

10.  Rad51 accumulation at sites of DNA damage and in postreplicative chromatin.

Authors:  S Tashiro; J Walter; A Shinohara; N Kamada; T Cremer
Journal:  J Cell Biol       Date:  2000-07-24       Impact factor: 10.539

View more
  105 in total

Review 1.  The role of PARP1 in the DNA damage response and its application in tumor therapy.

Authors:  Zhifeng Wang; Fengli Wang; Tieshan Tang; Caixia Guo
Journal:  Front Med       Date:  2012-06-03       Impact factor: 4.592

Review 2.  Investigational agents in development for the treatment of ovarian cancer.

Authors:  Shannon N Westin; Thomas J Herzog; Robert L Coleman
Journal:  Invest New Drugs       Date:  2012-06-04       Impact factor: 3.850

3.  Frequent recombination in telomeric DNA may extend the proliferative life of telomerase-negative cells.

Authors:  Susan M Bailey; Mark A Brenneman; Edwin H Goodwin
Journal:  Nucleic Acids Res       Date:  2004-07-16       Impact factor: 16.971

4.  The ups and downs of DNA repair biomarkers for PARP inhibitor therapies.

Authors:  Xiaozhe Wang; David T Weaver
Journal:  Am J Cancer Res       Date:  2010-01-03       Impact factor: 6.166

Review 5.  Fine tuning chemotherapy to match BRCA1 status.

Authors:  Melissa Price; Alvaro N A Monteiro
Journal:  Biochem Pharmacol       Date:  2010-05-25       Impact factor: 5.858

Review 6.  Mouse models of inherited cancer syndromes.

Authors:  Sohail Jahid; Steven Lipkin
Journal:  Hematol Oncol Clin North Am       Date:  2010-12       Impact factor: 3.722

7.  14-3-3σ Contributes to Radioresistance By Regulating DNA Repair and Cell Cycle via PARP1 and CHK2.

Authors:  Yifan Chen; Zhaomin Li; Zizheng Dong; Jenny Beebe; Ke Yang; Liwu Fu; Jian-Ting Zhang
Journal:  Mol Cancer Res       Date:  2017-01-13       Impact factor: 5.852

8.  Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers.

Authors:  Chaoyang Sun; Yong Fang; Jun Yin; Jian Chen; Zhenlin Ju; Dong Zhang; Xiaohua Chen; Christopher P Vellano; Kang Jin Jeong; Patrick Kwok-Shing Ng; Agda Karina B Eterovic; Neil H Bhola; Yiling Lu; Shannon N Westin; Jennifer R Grandis; Shiaw-Yih Lin; Kenneth L Scott; Guang Peng; Joan Brugge; Gordon B Mills
Journal:  Sci Transl Med       Date:  2017-05-31       Impact factor: 17.956

9.  Prostate cancer: unmet clinical needs and RAD9 as a candidate biomarker for patient management.

Authors:  Howard B Lieberman; Alex J Rai; Richard A Friedman; Kevin M Hopkins; Constantinos G Broustas
Journal:  Transl Cancer Res       Date:  2018-01-14       Impact factor: 1.241

10.  Conservative homologous recombination preferentially repairs DNA double-strand breaks in the S phase of the cell cycle in human cells.

Authors:  Nasrollah Saleh-Gohari; Thomas Helleday
Journal:  Nucleic Acids Res       Date:  2004-07-13       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.